# Marker Therapeutics (MRKR.US)

Canonical: https://gigainvestors.com/s/MRKR

Analysis as of: 2026-10-16T07:30:22.463Z. 

Listing currency: USD. Reporting currency: USD.

## Verdict

Not enough history yet

Quality tests for Buy: not passed (profit record: fail; earnings resilience is evidence only). Published buy qualification: no.

Share price: $0.92 per share; close as of 2026-10-15.

## Checklist

### understandable: na

### moat: na

### economics: na

### management: na

### accounting: na

## Holders

## Price story

Down 84% since Aug 2023

Story as of 2026-10-16T10:01:29.734Z; price observation 2026-10-15.

## Owner memo

Memo as of 2026-10-16T08:06:05.509Z.

### Where the cash goes

Paid no dividends in 3 years.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-03-18); Dividend observations: [[2021,0],[2022,0],[2023,0]]. Zero only counted when supported by a complete cash-flow statement.

### What the price says

The price is 0.8 times net assets.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-03-18); Closing price 0.92 USD; reporting-to-trading FX 1; FY2025 net assets per share 1.0970918416533488; price multiple 0.8385806594036227. FY2023 cash earnings/share -1.963614473750826. Closing-price date 2026-10-15.

## Monthly share-price history (USD per share)

- 2016-10: $5.00 per share

- 2016-11: $4.54 per share

- 2016-12: $3.88 per share

- 2017-01: $4.18 per share

- 2017-02: $4.51 per share

- 2017-03: $4.49 per share

- 2017-04: $4.20 per share

- 2017-05: $3.90 per share

- 2017-06: $3.88 per share

- 2017-07: $3.25 per share

- 2017-08: $3.25 per share

- 2017-09: $3.01 per share

- 2017-10: $3.02 per share

- 2017-11: $2.78 per share

- 2017-12: $3.92 per share

- 2018-01: $3.90 per share

- 2018-02: $3.25 per share

- 2018-03: $3.38 per share

- 2018-04: $2.65 per share

- 2018-05: $5.16 per share

- 2018-06: $9.43 per share

- 2018-07: $7.01 per share

- 2018-08: $8.62 per share

- 2018-09: $9.05 per share

- 2018-10: $9.02 per share

- 2018-11: $7.06 per share

- 2018-12: $5.55 per share

- 2019-01: $5.29 per share

- 2019-02: $6.22 per share

- 2019-03: $6.60 per share

- 2019-04: $5.28 per share

- 2019-05: $5.61 per share

- 2019-06: $7.92 per share

- 2019-07: $4.61 per share

- 2019-08: $5.17 per share

- 2019-09: $5.11 per share

- 2019-10: $3.84 per share

- 2019-11: $3.34 per share

- 2019-12: $2.88 per share

- 2020-01: $2.59 per share

- 2020-02: $2.47 per share

- 2020-03: $1.90 per share

- 2020-04: $2.76 per share

- 2020-05: $2.27 per share

- 2020-06: $2.07 per share

- 2020-07: $2.01 per share

- 2020-08: $1.80 per share

- 2020-09: $1.50 per share

- 2020-10: $1.36 per share

- 2020-11: $1.70 per share

- 2020-12: $1.45 per share

- 2021-01: $1.92 per share

- 2021-02: $2.42 per share

- 2021-03: $2.24 per share

- 2021-04: $2.56 per share

- 2021-05: $2.91 per share

- 2021-06: $2.79 per share

- 2021-07: $2.09 per share

- 2021-08: $1.98 per share

- 2021-09: $1.69 per share

- 2021-10: $1.47 per share

- 2021-11: $1.18 per share

- 2021-12: $0.95 per share

- 2022-01: $0.61 per share

- 2022-02: $0.38 per share

- 2022-03: $0.44 per share

- 2022-04: $0.34 per share

- 2022-05: $0.30 per share

- 2022-06: $0.33 per share

- 2022-07: $0.32 per share

- 2022-08: $0.31 per share

- 2022-09: $0.37 per share

- 2022-10: $0.44 per share

- 2022-11: $0.30 per share

- 2022-12: $0.27 per share

- 2023-01: $2.80 per share

- 2023-02: $2.17 per share

- 2023-03: $0.71 per share

- 2023-04: $0.84 per share

- 2023-05: $1.78 per share

- 2023-06: $3.10 per share

- 2023-07: $5.05 per share

- 2023-08: $5.62 per share

- 2023-09: $4.54 per share

- 2023-10: $2.40 per share

- 2023-11: $2.76 per share

- 2023-12: $5.50 per share

- 2024-01: $4.64 per share

- 2024-02: $3.63 per share

- 2024-03: $4.30 per share

- 2024-04: $4.05 per share

- 2024-05: $3.87 per share

- 2024-06: $5.43 per share

- 2024-07: $4.89 per share

- 2024-08: $3.61 per share

- 2024-09: $2.82 per share

- 2024-10: $4.05 per share

- 2024-11: $3.50 per share

- 2024-12: $3.11 per share

- 2025-01: $1.84 per share

- 2025-02: $1.53 per share

- 2025-03: $1.23 per share

- 2025-04: $1.19 per share

- 2025-05: $1.56 per share

- 2025-06: $1.53 per share

- 2025-07: $1.40 per share

- 2025-08: $0.93 per share

- 2025-09: $0.89 per share

- 2025-10: $0.99 per share

- 2025-11: $1.24 per share

- 2025-12: $1.49 per share

- 2026-01: $1.60 per share

- 2026-02: $1.48 per share

- 2026-03: $1.30 per share

- 2026-04: $1.46 per share

- 2026-05: $1.57 per share

- 2026-06: $1.47 per share

- 2026-07: $1.13 per share

- 2026-08: $1.33 per share

- 2026-09: $1.07 per share

- 2026-10: $0.92 per share

## Annual estimated value (USD per share)

Historical values use today's bond yield for every fiscal year

Historical values use today's FX rate into trading currency for every fiscal year

Historical values use current restated fundamentals and current commodity classification; they are not point-in-time estimates

## Sources

[Original 10-K filing](https://www.sec.gov/Archives/edgar/data/1094038/000110465926031274/mrkr-20251231x10k.htm); period 2025-12-31, filed 2026-03-18.

Estimates depend on assumptions and are not guarantees or investment advice. Underlying data remains subject to its source licenses; public reading does not grant bulk redistribution rights.

## Reported holder observations



# MRKR — Marker Therapeutics Inc.

Held by 1 investor · USD 19,950 total · 2026 Q1 · reported price USD 1.33 (split-adjusted).
Page: https://gigainvestors.com/s/MRKR

## Holders (2026 Q1)

| Investor | Value | % of their portfolio | This quarter |
|---|---:|---:|---|
| David Katz (https://gigainvestors.com/MAVFX) | USD 19,950 | 0.0% | hold |

## Total held by quarter

- 2021 Q4: USD 142,950 · 1 holder · USD 9.53
- 2022 Q1: USD 66,000 · 1 holder · USD 4.40
- 2022 Q2: USD 83,000 · 1 holder · USD 3.32
- 2022 Q3: USD 148,000 · 1 holder · USD 3.70
- 2022 Q4: USD 68,000 · 1 holder · USD 2.72
- 2023 Q1: USD 18,000 · 1 holder · USD 0.72
- 2023 Q2: USD 124,000 · 1 holder · USD 3.10
- 2023 Q3: USD 67,950 · 1 holder · USD 4.53
- 2023 Q4: USD 82,950 · 1 holder · USD 5.53
- 2024 Q1: USD 64,950 · 1 holder · USD 4.33
- 2024 Q2: USD 81,000 · 1 holder · USD 5.40
- 2024 Q3: USD 42,000 · 1 holder · USD 2.80
- 2024 Q4: USD 46,950 · 1 holder · USD 3.13
- 2025 Q1: USD 18,000 · 1 holder · USD 1.20
- 2025 Q2: USD 22,950 · 1 holder · USD 1.53
- 2025 Q3: USD 13,050 · 1 holder · USD 0.87
- 2025 Q4: USD 22,050 · 1 holder · USD 1.47
- 2026 Q1: USD 19,950 · 1 holder · USD 1.33
- 2026 Q2: USD 0 · 0 holders